Public Consultation on EMA Draft Q&A: Co-Processed Excipients in Solid Oral Dosage Forms The European Medicines Agency (EMA) has published the draft questions and answers regarding co-processed excipients used in solid oral dosage forms for public consultation. Public Consultation on EMA Draft Q&A: Co-Processed Excipients in Solid Oral Dosage Forms
MHRA Performance Data for Assessment of Clinical Trials and Established Medicines The MHRA performance metrics for clinical trials and established medicines assessment have been updated. MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
PAGB Webinar: Electronic Patient Information – the way forward for OTC medicines? As part of the new series of webinars, exclusive for PAGB members, we’re tackling important issues on the environment and sustainability in consumer healthcare. Join us for our next free webinar in the series on 2 October which will focus on Electronic Patient Information (ePI). PAGB Webinar: Electronic Patient Information – the way forward for OTC medicines?
2024 DSIT Research and Innovation Workforce Survey The Department for Science, Innovation and Technology (DSIT) is conducting the 2024 Research and Innovation (R&I) Workforce Survey. The results will impact UK government policy and R&D funding decisions. 2024 DSIT Research and Innovation Workforce Survey
Windsor Framework – Guidance Update The MHRA has updated its collection with new guidance for wholesalers and manufacturers, following the agreement on the Windsor Framework. Windsor Framework – Guidance Update
Established Medicines Application Process Changes MHRA has updated the guidance on process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products. The guidance has been amended to detail changes in application process. Established Medicines Application Process Changes
MHRA Consultation on Statutory Fees Proposals MHRA has launched a consultation on proposals to update the MHRA's statutory fees to ensure they continue to recover their costs. MHRA Consultation on Statutory Fees Proposals
EMA Account Management System Webinar EMA is hosting a webinar to give an overview on the new functionalities of the EMA account management system. EMA Account Management System Webinar
MHRA Pharmacovigilance Following Agreement of Windsor Framework Guidance MHRA has published guidance on the implementation of changes to pharmacovigilance for medicines authorised in the UK following the agreement of the Windsor Framework. MHRA Pharmacovigilance Following Agreement of Windsor Framework Guidance
August 2024 Update from The UK ePI Task Force An update for August on activities by the UK Electronic Patient Information (ePI) Task Force has been shared. The UK ePI Task Force is a cross-industry initiative led by PAGB, ABPI and BGMA with the purpose to facilitate a move to user-centered, digital-first medicines information that is inclusive and accessible for all, better for patients and the environment. August 2024 Update from The UK ePI Task Force
MHRA Windsor Framework Webinar MHRA is running a Windsor Framework Industry Webinar between 10:30am – 12:00pm on Thursday 19 September 2024. The aim of this webinar is to ensure the industry is best placed to understand changes made to guidance and make any relevant changes themselves in preparation for the Windsor Framework implementation date. MHRA Windsor Framework Webinar
Draft EU Herbal Monograph on Cisti cretici herba Further to its adoption by the EMA Committee on Herbal Medicinal Products (HMPC) in July 2024, the draft European Union herbal monograph on Cistus creticus L., herba has been published for public consultation. Draft EU Herbal Monograph on Cisti cretici herba
